Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05106647 · ClinicalTrials.gov registry record · NA
Reducing Work-related Screen Time in Health Care Workers During Leisure Time
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 520
- Enrollment target
NCT05106647: Completed NA study, sponsored by University of Nebraska.
NCT05106647 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 520 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05106647, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 520 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect that uninstalling work email applications from mobile devices during leisure time has on health care worker stress levels.
Primary Outcome
Individual scores on the Perceived Stress Scale can range from 0 to 40 with higher scores indicating higher perceived stress.
Interventions
- BEHAVIORAL Reduce screen time
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2023-11-05 |
| Phase | NA |
What the finished NCT05106647 record still lists
NCT05106647 is an interventional study that assigns participants to a tested intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 1 intervention - of which Reduce screen time is the first listed.
NCT05106647 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05106647 about?
NCT05106647 is a clinical study titled "Reducing Work-related Screen Time in Health Care Workers During Leisure Time". The purpose of this study is to determine the effect that uninstalling work email applications from mobile devices during leisure time has on health care worker stress levels.
What is the current status of trial NCT05106647?
This trial is currently completed. It is a NA study. The enrollment target is 520 participants. The study started on 2021-11-09. Estimated completion is 2023-11-05.
What interventions are being tested in trial NCT05106647?
The interventions under investigation include: Reduce screen time (BEHAVIORAL).
Who is sponsoring clinical trial NCT05106647?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05106647's enrollment target sits among peer trials
520 190th of 2000 higher than 1,810 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI